Nordea Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.9M Buy
951,594
+660,453
+227% +$63.3M 0.08% 219
2025
Q4
$28.1M Sell
291,141
-193,399
-40% -$18.8M 0.02% 331
2025
Q3
$45.8M Sell
484,540
-784,908
-62% -$72.2M 0.04% 275
2025
Q2
$111M Sell
1,269,448
-569,399
-31% -$48.3M 0.1% 207
2025
Q1
$164M Sell
1,838,847
-980,639
-35% -$87.8M 0.17% 146
2024
Q4
$225M Buy
2,819,486
+27,695
+1% +$2.4M 0.24% 117
2024
Q3
$250M Buy
2,791,791
+861,287
+45% +$72.5M 0.28% 96
2024
Q2
$152M Sell
1,930,504
-314,403
-14% -$25.8M 0.18% 146
2024
Q1
$195M Buy
2,244,907
+8,730
+0.4% +$745K 0.23% 120
2023
Q4
$185M Buy
2,236,177
+926,973
+71% +$70.6M 0.23% 119
2023
Q3
$103M Sell
1,309,204
-1,452,098
-53% -$122M 0.14% 166
2023
Q2
$244M Sell
2,761,302
-3,888,332
-58% -$335M 0.33% 82
2023
Q1
$529M Sell
6,649,634
-450,014
-6% -$36.7M 0.77% 26
2022
Q4
$548M Sell
7,099,648
-104,726
-1% -$8.49M 0.85% 23
2022
Q3
$600M Sell
7,204,374
-606,605
-8% -$54.5M 0.97% 21
2022
Q2
$699M Sell
7,810,979
-1,528,809
-16% -$155M 1.04% 22
2022
Q1
$1.05B Sell
9,339,788
-489,806
-5% -$51.7M 1.31% 8
2021
Q4
$1.03B Buy
9,829,594
+2,014,401
+26% +$233M 1.23% 11
2021
Q3
$996M Buy
7,815,193
+49,925
+0.6% +$6.46M 1.3% 10
2021
Q2
$964M Sell
7,765,268
-1,022,973
-12% -$128M 1.29% 13
2021
Q1
$1.04B Sell
8,788,241
-578,680
-6% -$67.8M 1.51% 8
2020
Q4
$1.1B Sell
9,366,921
-87,974
-0.9% -$9.68M 1.76% 7
2020
Q3
$975M Sell
9,454,895
-10,348,945
-52% -$1.04B 1.83% 7
2020
Q2
$1.77B Buy
19,803,840
+10,788,699
+120% +$1.03B 1.84% 7
2020
Q1
$809M Buy
9,015,141
+313,982
+4% +$33.4M 1.95% 7
2019
Q4
$980M Sell
8,701,159
-68,478
-0.8% -$7.51M 1.95% 7
2019
Q3
$949M Sell
8,769,637
-1,397,033
-14% -$146M 2.07% 4
2019
Q2
$991M Buy
10,166,670
+1,544,145
+18% +$141M 2.21% 3
2019
Q1
$785M Buy
8,622,525
+2,255,412
+35% +$202M 1.64% 6
2018
Q4
$579M Sell
6,367,113
-1,139,816
-15% -$107M 1.38% 15
2018
Q3
$738M Buy
+7,506,929
New +$694M 1.52% 11
2015
Q1
Sell
-4,554,050
Closed -$329M 910
2014
Q4
$329M Sell
4,554,050
-380,743
-8% -$26.4M 1.21% 23
2014
Q3
$306M Buy
4,934,793
+277,622
+6% +$17.7M 1.22% 21
2014
Q2
$297M Buy
4,657,171
+92,798
+2% +$5.64M 1.24% 22
2014
Q1
$281M Buy
4,564,373
+63,661
+1% +$3.71M 1.31% 23
2013
Q4
$258M Buy
4,500,712
+335,642
+8% +$19M 1.29% 19
2013
Q3
$222M Buy
4,165,070
+219,020
+6% +$11.8M 1.24% 20
2013
Q2
$203M Buy
+3,946,050
New +$195M 1.26% 21

Other funds holding MDT

Nordea Investment Management's MDT Position: Q1 2026 in Review

Nordea Investment Management increased its Medtronic (MDT) stake by 227% in Q1 2026, buying an estimated $63.3M and bringing the position to 951,594 shares worth $80.9M. The position accounts for 0.08% of the portfolio, ranked #219.

Nordea Investment Management first reported a position in MDT in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.77B in Q2 2020. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Nordea Investment Management held 951,594 shares of Medtronic worth $80.9M as of Q1 2026.
  • Nordea Investment Management bought 660,453 Medtronic shares in Q1 2026, an estimated $63.3M.
  • Medtronic made up 0.08% of Nordea Investment Management's portfolio in Q1 2026, its #219 holding.
  • Nordea Investment Management first reported a position in Medtronic in Q2 2013 and has held it in 38 quarters since.
  • Nordea Investment Management's Medtronic position peaked at $1.77B in Q2 2020.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.